Ebovax

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameEbovax

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Protein drugs > Recombinant proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHemorrhagic Fever, Ebola

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesVaxeal Holding SA

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVaxeal Holding SA

Active IndicationsN/A

Inactive IndicationsHemorrhagic Fever, Ebola

Other Information

ATC CodeN/A